Potential roles of NCAM/PSA-NCAM proteins in depression and the mechanism of action of antidepressant drugs

Pharmacological Reports

Volumn 65, Issue 6, 2013, Pages 1471-1478

  Wêdzony, Krzysztof ^a   Chocyk, Agnieszka ^a   Maækowiak, Marzena ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Antidepressant drugs; Depression; NCAM; PSA NCAM

Indexed keywords

AGOMELATINE; ANTIDEPRESSANT AGENT; FLUOXETINE; IMIPRAMINE; NERVE CELL ADHESION MOLECULE; POLYSIALYLATED NERVE CELL ADHESION MOLECULE; UNCLASSIFIED DRUG;

ANTIDEPRESSANT ACTIVITY; CELL PROLIFERATION; DEPRESSION; DRUG MECHANISM; DRUG TARGETING; EXPERIMENTAL MODEL; GENE INACTIVATION; HUMAN; MOLECULAR PATHOLOGY; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PROTEIN EXPRESSION; REVIEW;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSION; HUMANS; NEURAL CELL ADHESION MOLECULE L1; NEURAL CELL ADHESION MOLECULES; SIALIC ACIDS;

EID: 84894155360     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)71507-X     Document Type: Article

References (45)

1. Aonurm-Helm A, Jurgenson M, Zharkovsky T, Sonn K, Berezin V, Bock E, Zharkovsky A: Depression-like behaviour in neural cell adhesion molecule (NCAM)-deficient mice and its reversal by an NCAM-derived peptide, FGL. Eur J Neurosci, 2008, 28, 1618-1628.
2. Bessa JM, Morais M, Marques F, Pinto L, Palha JA, Almeida OF, Sousa N: Stress-induced anhedonia is associated with hypertrophy of medium spiny neurons of the nucleus accumbens. Transl Psychiatry, 2013, 3, 1-7.
3. Bora E, Fornito A, Pantelis C, Yucel M: Gray matter abnormalities in Major Depressive Disorder: a metaanalysis of voxel based morphometry studies. J Affect Disord, 2012, 138, 9-18.
4. Calandreau L, Marquez C, Bisaz R, Fantin M, Sandi C: Differential impact of polysialyltransferase ST8SiaII and ST8SiaIV knockout on social interaction and aggression. Genes Brain Behav, 2010, 9, 958-967.
5. Chocyk A, Dudys D, Przyborowska A, Maækowiak M, Wêdzony K: Impact of maternal separation on neural cell adhesion molecules expression in dopaminergic brain regions of juvenile, adolescent and adult rats. Pharmacol Rep, 2010, 62, 1218-1224.
6. Choi MR, Oh DH, Kim SH, Jung KH, Das ND, Chai YG: Fluoxetine increases the expression of NCAM140 and pCREB in rat C6 glioma cells. Psychiatry Investig, 2012, 9, 180-186.
7. Conboy L, Tanrikut C, Zoladz PR, Campbell AM, Park CR, Gabriel C, Mocaer E at al.: The antidepressant agomelatine blocks the adverse effects of stress on memory and enables spatial learning to rapidly increase neural cell adhesion molecule (NCAM) expression in the hippocampus of rats. Int J Neuropsychopharmacol, 2009, 12, 329-341.
8. Djordjevic A, Djordjevic J, Elakovic I, Adzic M, Matic G, Radojcic MB: Effects of fluoxetine on plasticity and apoptosis evoked by chronic stress in rat prefrontal cortex. Eur J Pharmacol, 2012, 693, 37-44.
9. Djordjevic A, Djordjevic J, Elakovic I, Adzic M, Matic G, Radojcic MB: Fluoxetine affects hippocampal plasticity, apoptosis and depressive-like behavior of chronically isolated rats. Prog Neuropsychopharmacol Biol Psychiatry, 2012, 36, 92-100.
10. Du MY, Wu QZ, Yue Q, Li J, Liao Y, Kuang WH, Huang XQ at al.: Voxelwise meta-analysis of gray matter reduction in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry, 2012, 36, 11-16.
11. Duman CH: Models of depression . Vitam Horm, 2010, 82, 1-21.
12. El MA, Rutishauser U: Use of PSA-NCAM in repair of the central nervous system. Adv Exp Med Biol, 2010, 663, 137-147.
13. Fang S, Yan B, Wang D, Bi X, Zhang Y, He J, Xu H et al.: Chronic effects of venlafaxine on synaptophysin and neuronal cell adhesion molecule in the hippocampus of cerebral ischemic mice. Biochem Cell Biol, 2010, 88, 655-663.
14. Gascon E, Vutskits L, Kiss JZ: Polysialic acid-neural cell adhesion molecule in brain plasticity: from synapses to integration of new neurons. Brain Res Rev, 2007, 56, 101-118. (Pubitemid 350100865)
15. Gilabert-Juan J, Varea E, Guirado R, Blasco-Ibanez JM, Crespo C, Nacher J: Alterations in the expression of PSA-NCAM and synaptic proteins in the dorsolateral prefrontal cortex of psychiatric disorder patients. Neurosci Lett, 2012, 530, 97-102.
16. Gómez-Climent MA, Guirado R, Castillo-Gómez E, Varea E, Gutierrez-Mecinas M, Gilabert-Juan J, Garcia-Mompó C et al.: The polysialylated form of the neural cell adhesion molecule (PSA-NCAM) is expressed in a subpopulation of mature cortical interneurons characterized by reduced structural features and connectivity. Cereb Cortex, 2011, 21, 1028-1041.
17. Guirado R, Sanchez-Matarredona D, Varea E, Crespo C, Blasco-Ibanez JM, Nacher J: Chronic fluoxetine treatment in middle-aged rats induces changes in the expression of plasticity-related molecules and in neurogenesis. BMC Neurosci, 2012, 13, 5-13.
18. Hinkle CL, Diestel S, Lieberman J, Maness PF: Metalloprotease-induced ectodomain shedding of neural cell adhesion molecule (NCAM). J Neurobiol, 2006, 66, 1378-1395. (Pubitemid 44713815)
19. Homberg JR, Olivier JD, Blom T, Arentsen T, van Brunschot, Schipper P, Korte-Bouws G et al.: Fluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat. PLoS One, 2011, 6, e16646.
20. Jaako K, Aonurm-Helm A, Kalda A, Anier K, Zharkovsky T, Shastin D, Zharkovsky A: Repeated citalopram administration counteracts kainic acid-induced spreading of PSA-NCAM-immunoreactive cells and loss of reelin in the adult mouse hippocampus. Eur J Pharmacol, 2011, 666, 61-71.
21. Jorgensen OS: Neural cell adhesion molecule (NCAM) and prealbumin in cerebrospinal fluid from depressed patients. Acta Psychiatr Scand Suppl, 1988, 345, 29-37.
22. Jurgenson M, Aonurm-Helm A, Zharkovsky A: Behavioral profile of mice with impaired cognition in the elevated plus-maze due to a deficiency in neural cell adhesion molecule. Pharmacol Biochem Behav, 2010, 96, 461-468.
23. Jurgenson M, Aonurm-Helm A, Zharkovsky A: Partial reduction in neural cell adhesion molecule (NCAM) in heterozygous mice induces depression-related behaviour without cognitive impairment. Brain Res, 2012, 1447, 106-118.
24. Lai CH: Gray matter volume in major depressive disorder: a meta-analysis of voxel-based morphometry studies. Psychiatry Res, 2013, 211, 37-46.
25. Maækowiak M, Chocyk A, Dudys D, Wedzony K: Activation of CB1 cannabinoid receptors impairs memory consolidation and hippocampal polysialylated neural cell adhesion molecule expression in contextual fear conditioning. Neuroscience, 2009, 158, 1708-1716.
26. Maækowiak M, Dudys D, Chocyk A, Wedzony K: Repeated risperidone treatment increases the expression of NCAM and PSA-NCAM protein in the rat medial prefrontal cortex. Eur Neuropsychopharmacol, 2009, 19, 125-137.
27. Maækowiak M, Grzegorzewska M, Budziszewska B, Chocyk A, Hess G, Wêdzony K: Cocaine decreases the expression of PSA-NCAM protein and attenuates longterm potentiation via glucocorticoid receptors in the rat dentate gyrus. Eur J Neurosci, 2008, 27, 2928-2937. (Pubitemid 351843398)
28. Maheu ME, Davoli MA, Turecki G, Mechawar N: Amygdalar expression of proteins associated with neuroplasticity in major depression and suicide. J Psychiatr Res, 2013, 47, 384-390.
29. Markram K, Gerardy-Schahn R, Sandi C: Selective learning and memory impairments in mice deficient for polysialylated NCAM in adulthood. Neuroscience, 2007, 144, 788-796. (Pubitemid 46013980)
30. Massart R, Mongeau R, Lanfumey L: Beyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depression. Philos Trans R Soc Lond B Biol Sci, 2012, 367, 2485-2494.
31. McEwen BS: Stress and hippocampal plasticity. Annu Rev Neurosci, 1999, 22, 105-122. (Pubitemid 29144882)
32. McEwen BS, Chattarji S, Diamond DM, Jay TM, Reagan LP, Svenningsson P, Fuchs E: The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation. Mol Psychiatry, 2010, 15, 237-249.
33. Miettinen R, Hajszan T, Riedel A, Szigeti-Buck K, Leranth C: Estimation of the total number of hippocampal CA1 pyramidal neurons: new methodology applied to helpless rats. J Neurosci Methods, 2012, 205, 130-138.
34. Nacher J, Guirado R, Castillo-Gomez E: Structural plasticity of interneurons in the adult brain: role of PSA-NCAM and implications for psychiatric disorders. Neurochem Res, 2013, 38, 1122-1133.
35. Nowacka M, Obuchowicz E: BDNF and VEGF in the pathogenesis of stress-induced affective diseases: An insight from experimental studies. Pharmacol Rep, 2013, 65, 535-546.
36. Ota KT, Duman RS: Environmental and pharmacological modulations of cellular plasticity: Role in the pathophysiology and treatment of depression. Neurobiol Dis, 2013, 57, 28-37.
37. Pillai-Nair N, Panicker AK, Rodriguiz RM, Gilmore KL, Demyanenko GP, Huang JZ, Wetsel WC, Maness PF: Neural cell adhesion molecule-secreting transgenic mice display abnormalities in GABAergic interneurons and alterations in behavior. J Neurosci, 2005, 25, 4659-4671. (Pubitemid 40637229)
38. Poltorak M, Frye MA, Wright R, Hemperly JJ, George MS, Pazzaglia PJ, Jerrels SA et al.: Increased neural cell adhesion molecule in the CSF of patients with mood disorder. J Neurochem, 1996, 66, 1532-1538. (Pubitemid 26090556)
39. Pompili M, Serafini G, Innamorati M, Venturini P, Fusar-Poli P, Sher L, Amore M, Girardi P: Agomelatine, a novel intriguing antidepressant option enhancing neuroplasticity: A critical review. World J Biol Psychiatry, 2013, 14, 412-431.
40. Radley JJ, Morrison JH: Repeated stress and structural plasticity in the brain Ageing Res Rev, 2005, 4, 271-287. (Pubitemid 41111982)
41. Sairanen M, O'Leary OF, Knuuttila JE, Castren E: Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat. Neuroscience, 2007, 144, 368-374. (Pubitemid 44839045)
42. Turner CA, Watson SJ, Akil H: The fibroblast growth factor family: neuromodulation of affective behavior. Neuron, 2012, 76, 160-174.
43. Varea E, Blasco-Ibanez JM, Gomez-Climent MA, Castillo-Gomez E, Crespo C, Martinez-Guijarro FJ, Nácher J: Chronic fluoxetine treatment increases the expression of PSA-NCAM in the medial prefrontal cortex. Neuropsychopharmacology, 2007, 32, 803-812. (Pubitemid 46426182)
44. Varea E, Guirado R, Gilabert-Juan J, Marti U, Castillo-Gomez E, Blasco-Ibanez JM, Crespo C, Nacher J: Expression of PSA-NCAM and synaptic proteins in the amygdala of psychiatric disorder patients. J Psychiatr Res, 2012, 46, 189-197.
45. Vawter MP, Frye MA, Hemperly JJ, VanderPutten DM, Usen N, Doherty P, Saffell JL et al.: Elevated concentration of N-CAM VASE isoforms in schizophrenia. J Psychiatr Res, 2000, 34, 25-34. (Pubitemid 30006938)